Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1993 1
1995 2
1997 1
1998 3
1999 3
2001 1
2002 2
2003 3
2004 2
2005 2
2006 1
2007 1
2010 1
2011 2
2012 1
2013 1
2014 2
2015 4
2016 3
2017 2
2018 2
2020 3
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany.
Bailey DL, Barthel H, Beuthin-Baumann B, Beyer T, Bisdas S, Boellaard R, Czernin J, Drzezga A, Ernemann U, Franzius C, Gückel B, Handgretinger R, Hartenbach M, Hellwig D, Nadel H, Nekolla SG, Pfluger T, Pichler BJ, Quick HH, Sabri O, Sattler B, Schäfer J, Schick F, Siegel BA, Schlemmer HP, Schwenzer NF, van den Hoff J, Veit-Haibach P, Wehrl HF. Bailey DL, et al. Among authors: guckel b. Mol Imaging Biol. 2014 Jun;16(3):295-310. doi: 10.1007/s11307-014-0725-4. Mol Imaging Biol. 2014. PMID: 24668195 Review.
Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany.
Bailey DL, Pichler BJ, Gückel B, Barthel H, Beer AJ, Bremerich J, Czernin J, Drzezga A, Franzius C, Goh V, Hartenbach M, Iida H, Kjaer A, la Fougère C, Ladefoged CN, Law I, Nikolaou K, Quick HH, Sabri O, Schäfer J, Schäfers M, Wehrl HF, Beyer T. Bailey DL, et al. Among authors: guckel b. Mol Imaging Biol. 2015 Oct;17(5):595-608. doi: 10.1007/s11307-015-0886-9. Mol Imaging Biol. 2015. PMID: 26286794 Review.
Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
Seith F, Forschner A, Weide B, Gückel B, Schwartz M, Schwenck J, Othman AE, Fenchel M, Garbe C, Nikolaou K, Schwenzer N, la Fougère C, Pfannenberg C. Seith F, et al. Among authors: guckel b. J Immunother Cancer. 2020 Aug;8(2):e000656. doi: 10.1136/jitc-2020-000656. J Immunother Cancer. 2020. PMID: 32753543 Free PMC article.
Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach.
Olthof SC, Forschner A, Martus P, Garbe C, Nikolaou K, la Fougère C, Gückel B, Vach W, Pfannenberg C. Olthof SC, et al. Among authors: guckel b. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2313-2321. doi: 10.1007/s00259-020-04733-x. Epub 2020 Mar 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 32123968
Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria.
Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KSJ, Gückel B, Jačan A, Haslacher H, Hicks RJ, Kenner L, Langanke M, Mitterhauser M, Pichler BJ, Salih HR, Schibli R, Schulz S, Simecek J, Simon J, Soares MO, Stelzl U, Wadsak W, Zatloukal K, Zeitlinger M, Hacker M. Lim MS, et al. Among authors: guckel b. Mol Imaging Biol. 2020 Feb;22(1):47-65. doi: 10.1007/s11307-019-01361-2. Mol Imaging Biol. 2020. PMID: 31049831
Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.
Bailey DL, Pichler BJ, Gückel B, Antoch G, Barthel H, Bhujwalla ZM, Biskup S, Biswal S, Bitzer M, Boellaard R, Braren RF, Brendle C, Brindle K, Chiti A, la Fougère C, Gillies R, Goh V, Goyen M, Hacker M, Heukamp L, Knudsen GM, Krackhardt AM, Law I, Morris JC, Nikolaou K, Nuyts J, Ordonez AA, Pantel K, Quick HH, Riklund K, Sabri O, Sattler B, Troost EGC, Zaiss M, Zender L, Beyer T. Bailey DL, et al. Among authors: guckel b. Mol Imaging Biol. 2018 Feb;20(1):4-20. doi: 10.1007/s11307-017-1123-5. Mol Imaging Biol. 2018. PMID: 28971346 Free PMC article.
HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy.
Peper JK, Bösmüller HC, Schuster H, Gückel B, Hörzer H, Roehle K, Schäfer R, Wagner P, Rammensee HG, Stevanović S, Fend F, Staebler A. Peper JK, et al. Among authors: guckel b. Oncoimmunology. 2015 Jul 1;5(5):e1065369. doi: 10.1080/2162402X.2015.1065369. eCollection 2016 May. Oncoimmunology. 2015. PMID: 27467910 Free PMC article.
43 results